Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Europe
Biotech
US biotechs thinking twice about licensing drugs to Europe
U.S. biotechs are increasingly reluctant to license their drugs to European partners in order to avoid becoming a target of the Trump administration.
James Waldron
Sep 26, 2025 8:09am
CRO Comac taps new CEO while boosting global footprint
Apr 30, 2025 4:33pm
Ferrer nabs European rights for ALS asset in €500M pact
Apr 28, 2025 2:40pm
Europe looks to attract US scientists amid research cuts
Mar 21, 2025 11:16am
Sofinnova closes €165M European biotech acceleration fund
Mar 18, 2025 4:01am
Sofinnova's €1.2B to fuel up to 60 life sciences companies
Mar 4, 2025 4:56am
